ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, dBET6 induced apoptosis in CML LSC obtained from patients with TKI‐resistant CML exhibiting BCR::ABL1 T315I or BCR::ABL1 F317L (Figure 3B).